YanLing He

4PUBLICATIONS
16CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Molecular medicineMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 16, 2024
A Growth Differentiation Factor 15 Receptor Agonist in Randomized Placebo-Controlled Trials in Healthy or Obese Persons.

William B Smith, David Nguyen, Timothy Clough

|Oct 25, 2022
Translational Population-Pharmacodynamic Modeling of a Novel Long-Acting siRNA Therapy, Inclisiran, for the Treatment of Hypercholesterolemia.

Nathalie H Gosselin, Virna J A Schuck, Olivier Barriere

|Jan 29, 2021
Glucosuric, renal and haemodynamic effects of licogliflozin, a dual inhibitor of sodium-glucose co-transporter-1 and sodium-glucose co-transporter-2, in patients with chronic kidney disease: A randomized trial.

YanLing He, Alok Pachori, Ping Chen

|Feb 07, 2019
The effects of licogliflozin, a dual SGLT1/2 inhibitor, on body weight in obese patients with or without diabetes.

Yan-Ling He, William Haynes, Charles D Meyers

Pageof 1

Frequent Collaborators

1 joint publications

Olivier Barriere

1 joint publications

William B Smith

1 joint publications

David Nguyen

1 joint publications

Timothy Clough